You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PROCHLORPERAZINE MALEATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Prochlorperazine Maleate, and when can generic versions of Prochlorperazine Maleate launch?

Prochlorperazine Maleate is a drug marketed by Ajanta Pharma Ltd, Amneal, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Leading, Norvium Bioscience, Novitium Pharma, Teva Pharms, and Zydus Lifesciences. and is included in fifteen NDAs.

The generic ingredient in PROCHLORPERAZINE MALEATE is prochlorperazine maleate. There are twenty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Prochlorperazine Maleate

A generic version of PROCHLORPERAZINE MALEATE was approved as prochlorperazine maleate by NOVITIUM PHARMA on June 13th, 2022.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROCHLORPERAZINE MALEATE?
  • What are the global sales for PROCHLORPERAZINE MALEATE?
  • What is Average Wholesale Price for PROCHLORPERAZINE MALEATE?
Drug patent expirations by year for PROCHLORPERAZINE MALEATE
Drug Prices for PROCHLORPERAZINE MALEATE

See drug prices for PROCHLORPERAZINE MALEATE

Drug Sales Revenue Trends for PROCHLORPERAZINE MALEATE

See drug sales revenues for PROCHLORPERAZINE MALEATE

Pharmacology for PROCHLORPERAZINE MALEATE
Drug ClassPhenothiazine

US Patents and Regulatory Information for PROCHLORPERAZINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Lifesciences PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 216495-002 Aug 8, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ajanta Pharma Ltd PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 218515-001 May 9, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Sub Teva Pharms PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 040162-002 Jan 20, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novitium Pharma PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 216202-002 Jun 13, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 040101-001 Jul 19, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 216598-002 Apr 17, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.